Jim Christensen
Internal Medicine · Las Vegas, NVNPI 1700830015
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 278 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,913 and has fallen 90.0% since, to $292 in 2025. Among internal medicine clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 278 payments — averaging $18.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$975
- CSL Behring$588
- Viiv Healthcare Company$461
- Sanofi$310
- Pfizer$309
- Merck$289
- plus $2K from 29 others
What the payments were for
- Food & beverage$5,11197%
- Education$1493%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 47 | $975 |
| CSL Behring | 35 | $588 |
| Viiv Healthcare Company | 13 | $461 |
| Sanofi | 13 | $310 |
| Pfizer | 33 | $309 |
| Merck | 6 | $289 |
| Pharming Healthcare, Inc. | 5 | $258 |
| Regeneron Healthcare Solutions, Inc. | 26 | $237 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $233 |
| Shire North American Group Inc | 13 | $220 |
| Octapharma USA, Inc. | 9 | $183 |
| Genentech USA, Inc. | 6 | $150 |
| AstraZeneca | 10 | $147 |
| Novartis | 7 | $130 |
| Teva Pharmaceuticals USA, Inc. | 7 | $104 |
| Optinose US, Inc. | 4 | $76 |
| Johnson & Johnson | 4 | $68 |
| Boehringer Ingelheim | 4 | $60 |
| Bio Products Laboratory USA, Inc. | 2 | $51 |
| Lilly USA, LLC | 2 | $45 |
| Novo Nordisk | 2 | $36 |
| Electromed, Inc. | 3 | $35 |
| Actelion Pharmaceuticals US, Inc. | 2 | $32 |
| Dexcom, Inc. | 2 | $31 |
| Biocryst US Sales Co., LLC | 2 | $31 |
| AbbVie | 1 | $29 |
| Gilead | 1 | $24 |
| Grifols USA, LLC | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Advanced Respiratory, Inc | 1 | $20 |
| Biogen | 1 | $20 |
| Bristol Myers Squibb | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Insmed, Inc. | 1 | $14 |
| Astellas Pharma US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,260 in reported general payments places this provider in the 90th percentile of 1,071 internal medicine providers in Nevada.
Other internal medicine in Las Vegas
- Kevin DunsmoorLas Vegas$241K
- Robert ChiascioneLas Vegas$174K
- Dino GonzalezLas Vegas$126K
- Rosanne SugayLas Vegas$63K
- Chad HallLas Vegas$42K
- Zubin DamaniaLas Vegas$40K
- Audrey Sue CruzLas Vegas$34K
- Bashab BanerjiLas Vegas$26K
- Amaan ShafiLas Vegas$25K
- Sassan KavehLas Vegas$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.